Finance Watch: Resilience Raises $625m, Bringing New Cash To $1.2bn
Series D Round Combined With Prior Unannounced $600m Series C
The biomanufacturing firm National Resilience has raised more than $2bn in venture capital and millions more in fees from government and industry contracts since 2020. Also, Code Biotherapeutics raised $75m in series A cash, Concert grossed $66.4m and Amarin is cutting US jobs.
